ABACUS MEDICINE A/S: Financial statements 2021
CVR: 28111576
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ABACUS MEDICINE A/S (CVR 28111576) has filed annual accounts for 2021. In 2021, the company reported revenue of EUR 940,740,000 and a net result of EUR 415,000 compared with EUR 433,000 the year before. That is an increase of 41.8% compared with the year before. The profit margin was 0%. Equity in the 2021 report amounted to EUR 54,646,000. The solvency ratio was 25.3%.
- Revenue
- EUR 940,740,000
- Profit/Loss
- EUR 415,000
- Equity
- EUR 54,646,000
- Total Assets
- EUR 215,576,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 940.7M EUR | - | 415K EUR | 54.6M EUR | - |
| 2020 | 663.5M EUR | - | 433K EUR | 53M EUR | - |
| 2019 | 421.4M EUR | - | 829K EUR | 51.6M EUR | - |
| 2018 | 332.3M EUR | 40.8M EUR | 5.4M EUR | 14.4M EUR | - |
| 2017 | 253K | 22K | 4K | 10K | - |
Official annual report
Find more companies like ABACUS MEDICINE A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 29, 2021, Michala Fischer-Hansen has joined the board of directors of ABACUS MEDICINE A/S.
ABACUS MEDICINE A/S has published its annual report for 2020. Revenue came to DKK 663,501,000, and the net result was DKK 433,000.
About ABACUS MEDICINE A/S
ABACUS MEDICINE A/S is a Danish company of the type Aktieselskab based in København V, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ABACUS MEDICINE ApS. The management consists of Flemming Wagner. The board consists of Jens Albert Harsaae (chair), Alette Margaretha Verbeek, Anders Kunze Bønding and Flemming Wagner. The company is owned by Wagner Family Holding ApS and CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB. The company has 388 employees (2026). In 2025, the company reported revenue of EUR 1,817,637,000 and a net result of EUR 7,779,000 compared with EUR 17,621,000 the year before. Equity in the 2025 report amounted to EUR 98,523,000.